Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,107 hedge funds and large institutions have $79B invested in Allergan plc in 2016 Q2 according to their latest regulatory filings, with 169 funds opening new positions, 500 increasing their positions, 363 reducing their positions, and 172 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 500 | Existing positions reduced: 363
5% more call options, than puts
Call options by funds: $4.83B | Put options by funds: $4.61B
2% less first-time investments, than exits
New positions opened: 169 | Existing positions closed: 172
1% less funds holding
Funds holding: 1,119 → 1,107 (-12)
15% less capital invested
Capital invested by funds: $92.6B → $79B (-$13.6B)
26% less funds holding in top 10
Funds holding in top 10: 155 → 115 (-40)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Icahn Carl
Sunny Isles Beach,
Florida
|
+$784M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$717M |
| 3 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$491M |
| 4 |
Lazard Asset Management
New York
|
+$485M |
| 5 |
Jennison Associates
New York
|
+$437M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.03B |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$703M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$678M |
| 4 |
EPCM
Eton Park Capital Management
New York
|
-$503M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$480M |
AGN Hedge Fund Activity: Q2 2016 in Review
1,107 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2016, worth a combined $79B — down 15% from $92.6B a quarter earlier.
Sellers outnumbered buyers: 172 funds closed out of AGN and 169 opened new positions — a net loss of 3 holders — while 363 trimmed existing stakes and 500 added.
The largest buyer was Icahn Carl, opening a new position worth an estimated $784M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.03B.
- 1,107 institutional investors held Allergan plc (AGN) as of Q2 2016, down from 1,119 in Q1 2016.
- Funds reported $79B of Allergan plc stock for Q2 2016, down 15% quarter-over-quarter.
- 169 funds opened new Allergan plc positions in Q2 2016 and 172 closed out, a net change of -3 holders.
- The largest Allergan plc buyer in Q2 2016 was Icahn Carl, an estimated $784M added.
- The largest Allergan plc seller in Q2 2016 was T. Rowe Price Associates, an estimated $1.03B sold.
Based on aggregated 13F filings for Q2 2016.